NCT01580241View on ClinicalTrials.gov

Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

July 31, 2015

Study Completion Date

December 31, 2024

Conditions
Pancreatic Cancer
Trial Locations (1)

73104

Stephensen Cancer Center, Oklahoma City

All Listed Sponsors
lead

University of Oklahoma

OTHER